Feasibility and safety of robotic radical resection for hilar cholangiocarcinoma in highly selected patients: A systematic review and meta-analysis with meta-regression.

Summary: Robotic Surgery for Bile Duct Cancer: A Precision Tool for Specific Patients

Hilar cholangiocarcinoma (a type of bile duct cancer) is notoriously difficult to treat, typically requiring complex open surgery. However, a new analysis of six studies involving nearly 300 patients suggests that robotic surgery is a viable alternative—but only for a very specific group of people.

The study found that robotic removal of these tumors is safe and effective, achieving a high rate of complete cancer removal (82%) and low death rates (less than 2%). The catch? These positive results were found in highly selected patients who were thinner (BMI under 25) and had smaller tumors (under 3 cm). For these candidates, robotic surgery offers a feasible option with acceptable operative times and blood loss.